Agilent and BGI have announced that they are to develop methodologies for next-generation genome-wide association studies.
Agilent and BGI have announced that they are to develop methodologies for next-generation genome-wide association studies. These methodologies will in turn help scientists involved in disease and drug research.
Agilent and BGI have been working together over several years and the aim of this collaboration is to create a next-generation super exome using Agilent’s SureSelect technology. The super exome incorporates sequence regions believed to be more informative for specific human populations.
Hui Jiang, associate director of the science and technology department at BGI, commented, “BGI aims to develop research collaborations and provide support to scientists all over the world. Together with Agilent’s expertise, we can create more precise and accurate technology that can be deployed in large-scale research to better understand complex diseases, which may have differences between ethnicities.”
Robert Schueren, vice president and general manager of Agilent's genomics business, said, “Agilent has a comprehensive portfolio of market-leading solutions for genomics research. This partnership with BGI will not only add to this portfolio, but also further Agilent's mission to build products that enable life sciences discoveries and develop solutions that improve the human condition.”
For more information please visit ref="http://www.agilent.com">www.agilent.com
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.